Senior Corporate Counsel, Disclosure & Securities Law (Senior Director) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

10-12 years of experience at a law firm and/or a public company, preferably pharmaceutical experience
J.D. from an accredited U.S. law school and license to practice law in the U.S
Strong organizational acumen and maturity within a highly complex matrixed organization
Expertise in U.S. Securities and Exchange Commission (SEC) reporting requirements and governance principles
Strong judgment, execution, communication, and cross-functional collaboration skills
Experience supporting senior leadership and corporate transactions

Responsibilities

Provide legal guidance on appropriate method and timing of public disclosures, ensuring legal review and compliance with all statements made, including securities and regulatory law compliance for a public company
Establish and enforce unblinding lists and processes for all highly sensitive and material information within the company; implement securities trading holds as appropriate
Support SEC filings, including Forms 10-K, 10-Q, 8-K, Schedule 13D/G, Forms 3 and 4, and investor disclosures
Support corporate finance transactions, including securities offerings, debt/equity repurchases, and credit agreements
Collaborate with senior leadership, finance, and legal teams to align governance strategy with regulatory obligations
Provide legal counsel on securities and disclosure matters for a public company, managing the voluntary and required public disclosures initiated by Corporate Affairs and Investor Relations, among others, managing appropriate knowledge groups for highly sensitive and material information and implementing trading holds as appropriate
Support key governance functions and SEC-related activities, ensuring compliance and advising senior leadership

Skills

Securities Law

Disclosure Compliance

SEC Filings

10-K

10-Q

8-K

Schedule 13D/G

Forms 3 and 4

Trading Holds

Corporate Governance

Regulatory Compliance

Public Disclosures

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free